Randomized double-blind multi-dose trial of the oral factor-Xa inhibitor DU-176b versus LMW Heparin (Dalteparin) for prevention of venous thromboembolism after total hip replacement - Raskob, G; Cohen, A; Eriksson, B (Eur Heart J, 2008)
et al.